Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

NCT05145400 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Cancer

Interventions

DRUG: Isatuximab
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]